Pritesh Shah, Chief Commercial Officer at NovoCure Ltd (NVCR), sold 387 shares at $108.00 ($42K) on 2023-01-05, disclosed to the SEC on 2023-01-09.
Open-market sale of $42k NVCR by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| NVCR | SELL | 2023-03-07 | $3.3M | — | Filing → |
| NVCR | SELL | 2023-03-06 | $141K | — | Filing → |
| NVCR | SELL | 2023-03-02 | $294K | — | Filing → |